Scott Hammerman, MD
Dermatology · Providence, RINPI 1124382023
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 418 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,665 and has fallen 67.7% since, to $861 in 2025.
Across 418 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Galderma Laboratories, L.p.$892
- Revance Therapeutics, Inc.$577
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$562
- Dermavant Sciences, Inc.$519
- plus $4K from 22 others
What the payments were for
- Food & beverage$8,83997%
- Education$2983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 78 | $1,596 |
| Johnson & Johnson | 40 | $1,062 |
| Galderma Laboratories, L.p. | 15 | $892 |
| Revance Therapeutics, Inc. | 15 | $577 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 37 | $562 |
| Dermavant Sciences, Inc. | 37 | $519 |
| LEO Pharma Inc. | 23 | $389 |
| Lilly USA, LLC | 16 | $368 |
| Mayne Pharma Commercial LLC | 19 | $358 |
| Novartis | 15 | $345 |
| Sanofi | 16 | $330 |
| Sun Pharmaceutical Industries Inc. | 15 | $284 |
| Incyte Corporation | 20 | $282 |
| Pfizer | 12 | $264 |
| Amgen | 4 | $205 |
| Regeneron Healthcare Solutions, Inc. | 8 | $167 |
| Bristol Myers Squibb | 12 | $150 |
| VYNE Pharmaceuticals Inc. | 6 | $146 |
| Dermira, Inc. | 7 | $134 |
| Almirall LLC | 5 | $109 |
| EPI Health, LLC | 4 | $95 |
| UCB, Inc. | 3 | $81 |
| E.r. Squibb & Sons, L.L.C. | 2 | $51 |
| Merck | 3 | $50 |
| Aclaris Therapeutics, Inc. | 2 | $44 |
| Journey Medical Corporation | 2 | $34 |
| Organon | 1 | $27 |
| Mission Pharmacal Company | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,137 in reported general payments places this provider in the 85th percentile of 61 dermatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 27 | $1,193 |
| Triamcinolone Acetonide | 57 | $602 |
| Clindamycin Phosphate | 14 | $549 |
| Ketoconazole | 48 | $549 |
| Mupirocin | 52 | $393 |
| Doxycycline Hyclate | 14 | $195 |
| Nystatin | 13 | $172 |
| Hydrocortisone | 19 | $99 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Providence
- Helena KuhnProvidence$63K
- Martin WeinstockProvidence$62K
- Farah MoustafaProvidence$51K
- Abrar QureshiProvidence$38K
- Laura della TorreProvidence$9K
- Benjamin KahnProvidence$4K
- Rachel HoffmannProvidence$4K
- Jennie MugliaProvidence$2K
- Daniella ReimannProvidence$2K
- Gladys TelangProvidence$624
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.